Navigation Links
Cyprotex Introduces New Product Line Cloe(R) Select - a Portfolio of Bespoke ADME and PK Services
Date:4/2/2008

MACCLESFIELD, England, April 2 /PRNewswire-FirstCall/ -- Today, (2nd April 2008), Cyprotex announces that it is introducing a new product line, Cloe(R) Select. Cloe(R) Select is a portfolio of bespoke studies which can be customised to individual customer requirements. It complements the current range of Cloe(R) Screen assays to provide ADME (absorption, distribution, metabolism and excretion) and pharmacokinetic solutions from early discovery through to later stage development projects. As with Cloe(R) Screen, Cloe(R) Select meets the criteria set by the regulatory guidelines to provide constant confidence in the quality of the data.

The drug discovery and development process represents a number of pre-clinical phases which cover hit to lead, lead optimization and candidate selection. Cyprotex can now offer a fully integrated solution in the area of ADME and pharmacokinetics throughout this entire process. We have gained extensive knowledge in our field over the past 9 years, which is attributed to investing in high caliber committed scientists and by working with a large and diverse customer base.

Mr. Robert Atwater, Cyprotex's Chief Executive Officer, comments on the launch of this new product line. "Many of our customers rely on us for their ADME projects right from early screening projects through to IND submission. Building these relationships and ensuring that we can offer a flexible and broad range of screening options has been critical in the success of our business."

Cyprotex is a specialist provider of ADME data and pharmacokinetic predictive services. Our unique Cloe(R) Screen technology which couples robust protocols with state-of-the-art automation enables Cyprotex to offer an unrivalled combination of high quality, cost effective data with rapid turnaround. Introducing Cloe(R) Select ensures that Cyprotex can extend their offering to later stage more in-depth studies which require a more flexible approach. Cyprotex also has
'/>"/>

SOURCE Cyprotex Discovery Ltd
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SAFC Expands Hi-Potency API Manufacturing and Introduces Solid-Form Testing at Its Madison Facility
2. Caliper Life Sciences Introduces High Throughput RNA Assay to Improve Workflow in Gene Expression Studies
3. Small Bone Innovations Introduces the Artelon(R) STT Spacer to Increase Treatment Options for Thumb Arthritis
4. Small Bone Innovations Introduces New Distal Radius Plating System to Repair Complex Fractures
5. Advanced Instruments Introduces Worlds Fastest High Throughput Freezing Point Osmometer
6. Harmonex Introduces CliniCom(TM), a Breakthrough in Psychiatric Intake and Assessment Technology
7. Hill-Rom Introduces New Wound Therapy Surface With Innovative Safety and Treatment Features
8. Varian Medical Systems Introduces New and Improved VariSeed(TM) 8.0 Software for Permanent Seed Prostate Brachytherapy Treatments
9. Sigma-Aldrich Introduces N-TER Nanoparticle siRNA Transfection System for Delivery of siRNA Into Difficult-to-Transfect Cell Types
10. WHO Introduces the Helminth Drug Initiative With Special Supplement in the Expert Opinion on Drug Discovery
11. H&V Introduces HVision Technology Platform to Accelerate Development of Breakthrough Products
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... 2015 , ... RPS Diagnostics (RPS®) – a developer, manufacturer, ... A. Gregg, PhD, has joined RPS as Senior Vice President of Clinical and ... remarkable achievements in the medical device and diagnostics industries. , “Bob not only ...
(Date:8/4/2015)... , Aug. 4, 2015   California Cryobank Stem ... acquisition of LifeLine Cryogenics, an east coast cord blood ... New York tristate area. LifeLine clients will ... prepaid contracts will be honored. Since 1991, ... offering storage of sperm, eggs, embryos, and cord blood ...
(Date:8/3/2015)...  MiMedx Group, Inc. (NASDAQ: MDXG ), the ... patent-protected processes to develop and market advanced products and ... Medicine, Ophthalmic and Dental sectors of healthcare, announced today ... Annual Canaccord|Genuity Growth Conference in Boston, Massachusetts ... William C. Taylor , President and COO, and ...
(Date:8/3/2015)... -- E-QURE Corp. (OTCQB: EQUR), a Delaware ... Therapy device ("BST Device"), a new and novel electrotherapy ... wounds, today announced that the Company has signed its ... in medical devices, for the marketing and distribution of ... years old, sales, marketing and distribution company in ...
Breaking Biology Technology:RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 2RPS Diagnostics Welcomes Robert Gregg as Senior Vice President of Clinical and Regulatory Affairs 3FamilyCord Announces Acquisition of LifeLine Cryogenics 2MiMedx To Present At 35th Annual Canaccord|Genuity Growth Conference 2E-QURE Corp Signs Second Distribution Agreement in Israel 2E-QURE Corp Signs Second Distribution Agreement in Israel 3
... Varian Australia Pty Ltd Mulgrave, Victoria, Australia , ... Because of the low detection limit capability of the ultrasonic nebulizer ... determine trace and ultratrace levels in water samples 1 . The purpose ... to handle samples with significant amounts of dissolved solids, such as urine ...
... Bethany V. Pond, Jason S. Wood, and August Specht Varian, ... , Alprazolam (Xanax) and ... both before and after protein precipitation using Liquid Chromatography Electrospray Ionization ... Spectrometer to detect and accurately quantitate these drugs in the BSA ...
... Jason S. Wood, Ph.D. Varian, Inc. , ... Testing for drugs of abuse (DoA) is becoming more ... well as in sporting events. Non-heroin opiates such as morphine, oxycodone, ... in San Francisco, the number of emergency department mentions of oxycodone ...
Cached Biology Technology:Analysis of urine and seawater samples by ultrasonic nebulization with a high resolution ICP spectrometer 2Analysis of urine and seawater samples by ultrasonic nebulization with a high resolution ICP spectrometer 3Analysis of urine and seawater samples by ultrasonic nebulization with a high resolution ICP spectrometer 4Detection of Alprazolam and Temazepam in a Bovine Plasma Matrix Using the Varian 500-MS Ion Trap Mass Spectrometer 2Detection of Alprazolam and Temazepam in a Bovine Plasma Matrix Using the Varian 500-MS Ion Trap Mass Spectrometer 3Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS 2Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS 3Detection of Morphine and Morphine-Glucuronide in Saliva or Urine with a Rapid and Simple Method Without Derivatization on the Varian 500-MS 4
(Date:7/23/2015)... 2015 Aware, Inc. (NASDAQ: AWRE ), a ... results for its second quarter ended June 30, 2015.  ... $4.5 million, a decrease of 33% compared to $6.8 million ... second quarter of 2015 was $0.3 million, or $0.01 per ... diluted share, in the same period a year ago.  ...
(Date:7/21/2015)... 2015 Passwords have proven futile for ... recent U.S. Office of Personnel Management breach. Biometric ... conundrum, but developers and end-users are concerned about ... dilemma, Biometrics-as-a-Service provider HYPR Corp. announced today the ... third party integration. A video ...
(Date:7/9/2015)... SAN JOSE, Calif. , July 9, 2015 /PRNewswire/ ... human interface solutions, announced today that it will report ... 2015 on Thursday, July 30, 2015 after the close ... call for analysts and investors at 2:00 p.m. PT ... information.    To participate on the live ...
Breaking Biology News(10 mins):Aware, Inc. Reports Second Quarter 2015 Financial Results 2Aware, Inc. Reports Second Quarter 2015 Financial Results 3Aware, Inc. Reports Second Quarter 2015 Financial Results 4Aware, Inc. Reports Second Quarter 2015 Financial Results 5Aware, Inc. Reports Second Quarter 2015 Financial Results 6HYPR Corp. Launches Industry First Biometric Tokenization Platform 2HYPR Corp. Launches Industry First Biometric Tokenization Platform 3HYPR Corp. Launches Industry First Biometric Tokenization Platform 4Synaptics to Report Fourth Quarter, Fiscal Year 2015 Results on July 30 2
... Durham University have discovered a natural mechanism in plants that ... to better crop yields. Plants naturally slow their growth ... such as water shortage or high salt content in soil, ... making proteins that repress the growth of the plant. This ...
... vehicles that have fish-like sensations, advanced ship design and ... Research (ONR) on Dec. 23 learned they will receive ... The researchers have been selected for Presidential Early ... be honored at a ceremony at the White House ...
... genetic signature that implicates a key mechanism in the immune ... leukaemia. Acute lymphoblastic leukaemia or ALL is the most ... leukaemia for one in four ALL patients is a mutation ... fuse together. This genomic alteration happens before birth and kick ...
Cached Biology News:New discovery could stimulate plant growth and increase crop yields, researchers say 2White House lauds ONR-funded researchers for early success 2Immune system development linked to leukemia 2Immune system development linked to leukemia 3
A substrate for all AChE-based EIA kits....
... mass spectrometer enables high-throughput solutions for todays ... ion trap mass spectrometer is designed for ... fast cycle time and increased sensitivity of ... attractive price. The combination of fast ...
The Synergy HT utilizes a unique dual-optics design combined with monochromator wavelength selection to provide uncompromised performance in absorbance, fluorescence and luminescence reading modes. ...
... AGI provides both long and short-term enriched ... animals in both quarantine and non-quarantine settings ... are also available utilizing our state-of-the-art social ... is equipped with on site CDC quarantine ...
Biology Products: